Tumor-derived exosomes (including those from CRC cells) were shown to directly suppress the activity of effector T-cells by activating the expression of death ligands (eg, FasL, TRAIL), which can trigger the apoptotic death of activated T-cells [52, 53]. Here, FASLG is linked to neoplasm.